newsfilter
← Latest News
ACCESS Newswire·

From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story

SAN DIEGO, CA / ACCESS Newswire / May 26, 2026 / Biotech investors spend enormous amounts of time searching for "the next big thing." Most never stop to ask a more important question:What does sophisticated